Company Performance Metrics
Within a decade, all medicine will be precision medicine, with treatment guided by the genomics of the patient. Genomic testing is standard of care for a growing list of cancers, and emergent for heart, brain, and immune system disorders. But only 20% of US heath care systems have implemented precision medicine programs, largely due to software
and data integration challenges. Farsight Genome Systems is introducing a cloud-based platform for genomic data management to improve integration between the multiple stakeholders involved in Precision Medicine. Fully automated operation offers both high margins and extraordinary capital efficiency. Our patent-pending technology delivers clinical-grade analytic performance that is instrument and reagent-agnostic, establishing a durable sustainable competitive advantage.
